Mutations in NR4A2 associated with familial Parkinson disease

NR4A2, encoding a member of nuclear receptor superfamily, is essential for the differentiation of the nigral dopaminergic neurons. To determine whether NR4A2 is a susceptibility gene for Parkinson disease, we carried out genetic analyses in 201 individuals affected with Parkinson disease and 221 age-matched unaffected controls. We identified two mutations in NR4A2 associated with Parkinson disease (−291Tdel and −245T→G), which map to the first exon of NR4A2 and affect one allele in 10 of 107 individuals with familial Parkinson disease but not in any individuals with sporadic Parkinson disease (n = 94) or in unaffected controls (n = 221). The age at onset of disease and clinical features of these ten individuals were not different from those of individuals with typical Parkinson disease. The mutations resulted in a marked decrease in NR4A2 mRNA levels in transfected cell lines and in lymphocytes of affected individuals. Additionally, mutations in NR4A2 affect transcription of the gene encoding tyrosine hydroxylase. These data suggest that mutations in NR4A2 can cause dopaminergic dysfunction, associated with Parkinson disease.

[1]  M. Palkovits,et al.  Dopamine Biosynthesis Is Selectively Abolished in Substantia Nigra/Ventral Tegmental Area but Not in Hypothalamic Neurons in Mice with Targeted Disruption of the Nurr1 Gene , 1998, Molecular and Cellular Neuroscience.

[2]  L. Olson,et al.  Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. , 1996, Brain research. Molecular brain research.

[3]  B J Hoffer,et al.  Dopamine neuron agenesis in Nurr1-deficient mice. , 1997, Science.

[4]  J. Jankovic,et al.  Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced Injury , 1999, Journal of neurochemistry.

[5]  H. Kawakami,et al.  Organization of the human orphan nuclear receptor Nurr1 gene. , 1999, Gene.

[6]  J. Granneman,et al.  Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism , 2001, Journal of neurochemistry.

[7]  J. Haines,et al.  Complete genomic screen in Parkinson disease: evidence for multiple genes. , 2001, JAMA.

[8]  Hreinn Stefánsson,et al.  A susceptibility gene for late‐onset idiopathic Parkinson's disease , 2002, Annals of neurology.

[9]  R. Bravo,et al.  NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3. , 1994, Molecular endocrinology.

[10]  G. Sedvall,et al.  NURR1 mutations in cases of schizophrenia and manic-depressive disorder. , 2000, American journal of medical genetics.

[11]  S. Tsuji,et al.  A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1 , 2002, Annals of neurology.

[12]  J. Houwing-Duistermaat,et al.  Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. , 2001, American journal of human genetics.

[13]  H. Ichinose,et al.  Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs. , 1999, Gene.

[14]  M. Smidt,et al.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Nataraj,et al.  Single‐strand conformation polymorphism and heteroduplex analysis for gel‐based mutation detection , 1999, Electrophoresis.

[16]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[17]  C. H. Chen,et al.  Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients. , 2001, American journal of medical genetics.

[18]  B. Müller-Myhsok,et al.  A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.

[19]  Langston Jw.  Epidemiology versus genetics in parkinson's disease: Progress in resolving an age-old debate , 1998 .

[20]  O. Conneely,et al.  Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice , 1999, Experimental Neurology.

[21]  C. Kozak,et al.  Organization, sequence, chromosomal localization, and promoter identification of the mouse orphan nuclear receptor Nurr1 gene. , 1997, Genomics.

[22]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[23]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[24]  M. Farrer,et al.  A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. , 1999, Human molecular genetics.

[25]  J. Langston,et al.  Epidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate , 1998, Annals of neurology.

[26]  S. Hunt,et al.  Evidence for multiple genes determining sodium transport , 1994, Genetic epidemiology.

[27]  B. O’Malley,et al.  Identification of a new brain-specific transcription factor, NURR1. , 1992, Molecular endocrinology.

[28]  T. Iwawaki,et al.  Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells. , 2000, Biochemical and biophysical research communications.

[29]  A. Bentivoglio,et al.  Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. , 2001, American journal of human genetics.

[30]  J. Haines,et al.  Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. , 2001, JAMA.